[SLN] QoQ Quarter Result on 31-Mar-2018 [#Q1]

Stock
[SLN] Silence Therapeutics plc
Announcement Date
30-Mar-2018
Financial Year
2018
Quarter
31-Mar-2018 [#Q1]
Profit Trend
QoQ- -322.88%
YoY- -57.51%
Quarter Report
SLN's Result
SLN's Financial Summary
View:
Show?
Quarter Result
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
Revenue 0 0 0 0 0 0 8 -
PBT -5,370 -5,370 -4,894 -4,894 1,441 1,441 -3,328 37.45%
Tax 507 507 550 550 508 508 570 -7.49%
NP -4,862 -4,862 -4,344 -4,344 1,949 1,949 -2,758 45.78%
Tax Rate - - - - -35.30% -35.30% - -
Total Cost 4,862 4,862 4,344 4,344 -1,949 -1,949 2,766 45.49%
Ratio Analysis
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 -34,475.00 -
Per Share
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
EPS -0.21 -0.21 -0.19 -0.19 0.08 0.08 -0.12 45.07%
EPS Diluted -0.21 -0.21 -0.19 -0.19 0.08 0.08 -0.12 45.07%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.